サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571887

心臓血管および軟部組織修復パッチの世界市場

Cardiovascular and Soft Tissue Repair Patches

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
心臓血管および軟部組織修復パッチの世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓血管および軟部組織修復パッチの世界市場は2030年までに83億米ドルに達する見込み

2023年に51億米ドルと推定された心臓血管および軟部組織修復パッチの世界市場は、分析期間2023-2030年にCAGR 7.4%で成長し、2030年には83億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるePTFE原料は、CAGR 7.2%を記録し、分析期間終了時には50億米ドルに達すると予測されます。生体材料・組織工学材料セグメントの成長率は、分析期間中CAGR 7.9％と推定されます。

米国市場は13億米ドルと推定、中国はCAGR 11.1％で成長予測

米国の心臓血管および軟部組織修復パッチ市場は2023年に13億米ドルと推定されます。世界第2位の経済大国である中国は、2023～2030年の分析期間においてCAGR 11.1%で推移し、2030年までに20億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7%と6.7%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の心臓血管および軟部組織修復パッチ市場- 主要動向と促進要因のまとめ

心臓血管および軟部組織修復パッチはなぜ現代医療に不可欠なのか？

心臓血管および軟部組織修復パッチは、特に心臓手術や再建手術において、体内の損傷した組織や構造を修復するために使用される重要な医療機器です。これらのパッチは、合成材料または生物学的材料から作られ、組織の治癒を促進し、弱った部分を支え、臓器や組織の構造的完全性を回復するように設計されています。心臓血管への応用では、先天性心欠損、動脈瘤、弁膜症などの治療に用いられます。軟部組織の修復では、ヘルニアの修復、腹壁の再建、その他の外傷に関連する損傷に不可欠です。

心臓血管および軟部組織修復パッチの需要は、心血管疾患（CVDs）の有病率の増加や組織修復に関連する外科手術の件数の増加により大幅に増加しています。手術技術や材料の進歩により、これらのパッチは患者にとってより信頼性が高く耐久性のあるソリューションを提供し、より早い回復とより良い転帰を促進します。さらに、パッチ開発における生体適合性と生体吸収性材料の使用は、身体の自然治癒プロセスを強化し、感染症や免疫反応などの合併症を減少させる。これらのパッチは、患者の長期的な回復をサポートし、外科的再手術の可能性を減少させる能力から、現代医療において不可欠なものとなっています。

技術の進歩は心臓血管および軟部組織修復パッチ市場をどのように形成しているか？

技術の進歩は心臓血管および軟部組織修復パッチ市場に革命をもたらし、その有効性、耐久性、生体適合性を向上させています。重要な進歩のひとつは、生体工学パッチの使用です。これらのパッチは、コラーゲンやその他の生物学的な足場から作られることが多く、患者の体内に溶け込み、時間の経過とともに徐々に吸収されることで、自然な組織再生を促進します。これにより、拒絶反応のリスクが軽減され、治癒成績が向上します。さらに、組織が治癒した後に溶解する生体吸収性材料の使用により、パッチを除去するための再手術の必要性がなくなり、患者の快適性が向上し、ヘルスケアコストが削減されます。

もうひとつの大きな進歩は、耐久性と機械的強度を高めた合成パッチの開発です。ポリマー科学の革新により、高い機械的ストレスに耐えるパッチが開発され、心臓のようなダイナミックな環境での使用に適しています。生物学的成分と合成成分の両方を組み合わせたハイブリッド・パッチも、組織の成長を促しながら構造的なサポートを提供するという、両材料の利点を提供することから人気を集めています。さらに、3Dプリンティングとナノテクノロジーは、カスタマイズされたパッチの生産における変革ツールとして台頭してきており、外科医が個々の患者のニーズに合わせてパッチの形状やサイズを正確に調整することを可能にしています。

どのような医療および消費者動向が心臓血管および軟部組織修復パッチの需要を牽引しているのか？

いくつかの医療および消費者動向が心臓血管および軟部組織修復パッチの需要を形成しており、特に慢性疾患の有病率の増加や低侵襲手術の重視が高まっています。高齢化社会と肥満や高血圧のようなライフスタイル要因による心臓血管疾患の増加は、世界中で心臓手術の件数を大幅に増加させています。心臓血管パッチは、先天性欠損、動脈瘤、損傷した心臓弁を含む様々な心臓疾患の治療に不可欠であり、これらの医療機器に対する安定した需要を生み出しています。さらに、外傷関連の傷害の増加や、ヘルニアや軟部組織断裂などの症状に対する再建手術の増加により、信頼性の高い軟部組織修復ソリューションの必要性が高まっています。

需要を牽引するもう一つの大きな動向は、回復時間の短縮と合併症の減少をもたらす低侵襲手術への嗜好の高まりです。軟部組織修復パッチ、特に腹腔鏡手術用に設計されたものは、低侵襲のヘルニア修復や腹部手術でますます人気が高まっています。今日の患者は、より低侵襲な治療の利点をより認識しており、より早い回復と痛みの軽減を提供する処置を求めています。この種の手術に使用できる、高度で柔軟性のある生体吸収性パッチの開発は、低侵襲性の選択肢に対するこのような需要と一致しています。さらに、感染症やパッチの不具合といった術後合併症に対する意識の高まりから、外科医や医療提供者は患者の転帰を改善する高品質で生体適合性の高い素材を選択するようになっています。手術合併症の軽減と患者満足度の向上が重視され、心臓血管および軟部組織修復パッチのデザインと機能性の革新が促進されています。

心臓血管および軟部組織修復パッチ市場の成長はいくつかの要因別もたらされる

心臓血管および軟部組織修復パッチ市場の成長は、心血管障害や軟部組織障害の発生率の増加、パッチ素材やデザインの進歩、低侵襲手術ソリューションに対する需要の高まりなど、いくつかの要因によって牽引されています。主な促進要因の1つは、心血管系疾患の世界の負担の増大であり、これは依然として世界の死因の第1位です。動脈瘤、先天性心疾患、弁膜症などの疾患に対する手術件数の増加が、心臓血管修復パッチ、特に生体適合性と耐久性を改善したものに対する需要を促進しています。

生体工学および合成パッチ材料の技術的進歩も市場成長の重要な要因です。生体吸収性パッチや、生物学的成分と合成成分の最良の特性を組み合わせたハイブリッド材料などの革新は、これらのデバイスを患者にとってより効果的で安全なものにしています。さらに、患者固有の解剖学的ニーズに合わせてカスタマイズできる3Dプリントパッチの開拓が、個別化医療機器市場を拡大しています。低侵襲手術技術への注目の高まりが市場をさらに押し上げています。特にヘルニア修復のための腹腔鏡手術で使用される軟部組織修復パッチは、回復時間を短縮し、傷跡を最小限に抑えることができるため、高い需要があります。ヘルスケアプロバイダーがますます低侵襲アプローチを採用するようになるにつれて、柔軟で使いやすく高性能なパッチの需要が拡大すると予想されます。さらに、高度なヘルスケア・インフラの利用可能性が拡大し、新興市場におけるヘルスケア支出が増加することで、市場拡大の新たな機会が生まれています。世界のヘルスケアシステムが革新、安全性、患者中心のケアを優先し続ける中、心臓血管および軟部組織修復パッチ市場は持続的な成長を遂げる態勢が整っています。

調査対象企業の例（全42件）

  • Abbott（St Jude Medical）
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • W.L. Gore & Associates, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21438

Global Cardiovascular and Soft Tissue Repair Patches Market to Reach US$8.3 Billion by 2030

The global market for Cardiovascular and Soft Tissue Repair Patches estimated at US$5.1 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. ePTFE Raw Material, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$5.0 Billion by the end of the analysis period. Growth in the Biomaterial & Tissue Engineered Material segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 11.1% CAGR

The Cardiovascular and Soft Tissue Repair Patches market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Cardiovascular and Soft Tissue Repair Patches Market – Key Trends & Drivers Summarized

Why Are Cardiovascular and Soft Tissue Repair Patches Essential in Modern Medicine?

Cardiovascular and soft tissue repair patches are critical medical devices used to repair damaged tissues and structures within the body, particularly in cardiac surgeries and reconstructive procedures. These patches, made from either synthetic or biological materials, are designed to facilitate tissue healing, support weakened areas, and restore the structural integrity of organs and tissues. In cardiovascular applications, they are used to treat conditions like congenital heart defects, aneurysms, and valvular diseases. For soft tissue repair, these patches are essential in hernia repairs, abdominal wall reconstruction, and other trauma-related injuries.

The demand for cardiovascular and soft tissue repair patches has risen significantly due to the increasing prevalence of cardiovascular diseases (CVDs) and the growing number of surgical procedures related to tissue repair. With advancements in surgical techniques and materials, these patches provide a more reliable, durable solution for patients, promoting faster recovery and better outcomes. Furthermore, the use of biocompatible and bioresorbable materials in patch development enhances the body's natural healing processes, reducing complications such as infections or immune reactions. These patches have become indispensable in modern medicine for their ability to support long-term patient recovery and reduce the likelihood of surgical re-intervention.

How Are Technological Advancements Shaping the Cardiovascular and Soft Tissue Repair Patches Market?

Technological advancements are revolutionizing the cardiovascular and soft tissue repair patches market, improving their effectiveness, durability, and biocompatibility. One significant development is the use of bioengineered patches, which are designed to mimic the body’s natural tissues. These patches, often derived from collagen or other biological scaffolds, promote natural tissue regeneration by integrating into the patient’s body and gradually being absorbed over time. This reduces the risk of rejection and improves healing outcomes. Additionally, the use of bioresorbable materials that dissolve after the tissue has healed eliminates the need for follow-up surgeries to remove the patches, improving patient comfort and reducing healthcare costs.

Another major advancement is the development of synthetic patches with enhanced durability and mechanical strength. Innovations in polymer science have led to the creation of patches that can withstand high mechanical stresses, making them suitable for use in dynamic environments such as the heart. Hybrid patches, which combine both biological and synthetic components, are also gaining popularity as they offer the benefits of both materials, providing structural support while encouraging tissue growth. Furthermore, 3D printing and nanotechnology are emerging as transformative tools in the production of customized patches, allowing surgeons to tailor the shape and size of patches to fit individual patient needs precisely.

What Medical and Consumer Trends Are Driving the Demand for Cardiovascular and Soft Tissue Repair Patches?

Several medical and consumer trends are shaping the demand for cardiovascular and soft tissue repair patches, particularly the increasing prevalence of chronic diseases and the growing emphasis on minimally invasive procedures. The rise in cardiovascular diseases, driven by aging populations and lifestyle factors like obesity and hypertension, has significantly increased the number of cardiac surgeries worldwide. Cardiovascular patches are critical in treating a variety of heart conditions, including congenital defects, aneurysms, and damaged heart valves, creating a steady demand for these medical devices. Additionally, the rise in trauma-related injuries and the growing number of reconstructive surgeries for conditions like hernias and soft tissue tears have driven the need for reliable soft tissue repair solutions.

Another major trend driving demand is the growing preference for minimally invasive surgeries, which result in shorter recovery times and fewer complications. Soft tissue repair patches, especially those designed for laparoscopic procedures, have become increasingly popular in minimally invasive hernia repairs and abdominal surgeries. Patients today are more aware of the benefits of less invasive treatments and are seeking procedures that offer quicker recovery and reduced pain. The development of advanced, flexible, and bioresorbable patches that can be used in these types of surgeries is aligning with this demand for minimally invasive options. Moreover, the increasing awareness of postoperative complications, such as infections and patch failure, is prompting surgeons and healthcare providers to choose high-quality, biocompatible materials that improve patient outcomes. The emphasis on reducing surgical complications and enhancing patient satisfaction is fostering innovation in the design and functionality of cardiovascular and soft tissue repair patches.

Growth in the Cardiovascular and Soft Tissue Repair Patches Market Is Driven by Several Factors

Growth in the cardiovascular and soft tissue repair patches market is driven by several factors, including the increasing incidence of cardiovascular and soft tissue disorders, advancements in patch materials and design, and the rising demand for minimally invasive surgical solutions. One of the primary drivers is the growing global burden of cardiovascular diseases, which remains the leading cause of death worldwide. The increasing number of surgeries for conditions such as aneurysms, congenital heart defects, and valvular diseases is driving the demand for cardiovascular repair patches, particularly those that offer improved biocompatibility and durability.

Technological advancements in bioengineered and synthetic patch materials are another significant factor contributing to market growth. Innovations such as bioresorbable patches and hybrid materials that combine the best properties of biological and synthetic components are making these devices more effective and safer for patients. Additionally, the development of 3D-printed patches, which can be customized to match a patient’s specific anatomical needs, is expanding the market for personalized medical devices. The rising focus on minimally invasive surgical techniques is further boosting the market. Soft tissue repair patches, especially those used in laparoscopic surgeries for hernia repairs, are in high demand due to their ability to reduce recovery times and minimize scarring. As healthcare providers increasingly adopt minimally invasive approaches, the demand for flexible, easy-to-use, and high-performance patches is expected to grow. Moreover, the expanding availability of advanced healthcare infrastructure and rising healthcare spending in emerging markets are opening new opportunities for market expansion. As the global healthcare system continues to prioritize innovation, safety, and patient-centered care, the cardiovascular and soft tissue repair patches market is poised for sustained growth.

Select Competitors (Total 42 Featured) -

  • Abbott (St Jude Medical)
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • W.L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiovascular and Soft Tissue Repair Patches - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biomaterials and Biotechnology Drive Innovations in Cardiovascular and Soft Tissue Repair Patches
    • Increasing Incidences of Cardiovascular Diseases Worldwide Propel the Use of Repair Patches in Surgeries
    • Growth in Minimally Invasive Surgical Techniques Boosts Demand for Cardiovascular Patches
    • Innovations in Drug-Eluting and Bioactive Patches Enhance Healing and Functional Integration
    • Rising Demand for Durable and Biocompatible Soft Tissue Repair Solutions
    • Development of Synthetic and Natural Patches to Meet Diverse Clinical Needs
    • Expansion of Treatment Indications for Repair Patches Beyond Cardiovascular Applications
    • Consumer Awareness and Surgeon Advocacy Play Crucial Roles in the Adoption of New Patch Technologies
    • Technological Enhancements in Imaging and Placement Techniques for Precision in Patch Application
    • Market Trends Toward Customizable and Patient-Specific Repair Patch Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Biomaterial & Tissue Engineered Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiac Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Vascular Repair & Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pericardial Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Dural Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Cardiovascular and Soft Tissue Repair Patches Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030

IV. COMPETITION